GLP1R and type 2 diabetes mellitus: Glutamine was identified as a stimulus of GLP-1 secretion in vitro [56], and was subsequently found to trigger GLP-1 secretion in healthy volunteers [57] and to improve glucose tolerance in patients with type 2 diabetes when administered orally [58].